Abstract:Alzheimer's disease (AD) is a chronic neurodegenerative, and abnormal aggregation of the neurotoxic beta amyloid (A beta) peptide is an early event in AD. The present study aimed to determine the correlation between the nicotinic acetylcholine receptor alpha 7 subunit (alpha 7 nAChR) and A beta in the brains of patients with AD, and to investigate whether the increased expression levels of the alpha 7 nAChR could alter the neurotoxicity of A beta. The expression levels of alpha 7 nAChR and A beta in the brains of patients with AD and healthy brains were analyzed using immunofluorescence. Moreover, SH-SY5Y cells were used to stably overexpress or silence alpha 7 nAChR expression levels, prior to the treatment with or without 1 mu mol/l A beta(1-42) oligomer (A beta O). The mRNA and protein expression levels of alpha 7 nAChR, synaptophysin (SYP), postsynaptic density of 95 kDa (PSD-95) and synaptosomal-associated protein of 25 kDa (SNAP-25) were subsequently analyzed using reverse transcription-quantitative PCR and western blotting. In addition, the concentration of acetylcholine (ACh) and the activity of acetylcholinesterase (AChE) were analyzed using spectrophotometry, while the cell apoptotic rate was determined using flow cytometry. The expression of A beta in the brains of patients with AD was found to be significantly increased, whereas the expression of alpha 7 nAChR was significantly decreased compared with the healthy control group. In vitro, the expression levels of alpha 7 nAChR were significantly increased or decreased following the overexpression or silencing of the gene, respectively. Consistent with these observations, the mRNA and protein expression levels of SYP, PSD-95 and SNAP-25 were also significantly increased following the overexpression of alpha 7 nAChR and decreased following the genetic silencing of the receptor. In untransfected or negative control cells, the expression levels of these factors and the apoptotic rate were significantly reduced following the exposure to A beta O, which was found to be attenuated by alpha 7 nAChR overexpression, but potentiated by alpha 7 nAChR RNA silencing. However, no significant differences were observed in either the ACh concentration or AChE activity following transfection. Collectively, these findings suggested that alpha 7 nAChR may protect the brains of patients with AD against A beta, as alpha 7 nAChR overexpression increased the expression levels of SYP, SNAP-25 and PSD-95, and attenuated the inhibitory effect of A beta on the expression of these synaptic proteins and cell apoptosis. Overall, this indicated that alpha 7 nAChR may serve an important neuroprotective role in AD.

[Effects of Α3 Neuronal Nicotinic Acetylcholine Receptor on Cell Apoptosis and P38 MAPK Signal Transduction Pathway in SH-SY5Y Cells].

Inhibiting Gene Expression of Α3 Nicotinic Receptor in SH-SY5Y Cells with the Effects on APP Metabolism and Antioxidation in Alzheimer's Disease

[Influence of Inhibited Gene Expression of Alpha 3 Nicotinic Acetylcholine Receptor by RNA Interference on Anti-Oxidation in SH-SY5Y Cells].

The anti-inflammation of α3 neuronal nicotinic acetylcholine receptors in Alzheimer′s disease

P3–349: Inhibition of Secreted Alpha–app and Enhanced Neurotoxication of Beta–amyloid Peptide by Interference of Nicotinic Receptor Alpha7 Mrna in SH–SY5Y Cells

The consequences of reducing expression of the α7 nicotinic receptor by RNA interference and of stimulating its activity with an α7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease

Effects of α3 nicotinic receptor gene silence in SH-SYSY cells on the expression of β-secretase protein

[Influence of Inhibited Α7 Nicotinic Acetylcholine Receptor Gene Expression on the Production of Β-Amyloid Peptide in SH-SY5Y Cells].

Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells

Influence of inhibiting α7 neuronal nicotinic acetylcholine receptor mRNA on lipid peroxidation in SH-SY5Y cells

Effect of α3 neuronal nicotinic receptor gene up-regulated on the expression of SYP protein in SH-SY5Y cells

[Neuroprotective Effects of Alpha7 Neuronal Acetylcholine Receptor and Its Roles in the Pathogenesis of Alzheimer's Disease].

Influence of inhibited α7 nicotinic acetylcholine receptor protein expression on tau protein and p38 MAPK signal transduction pathway in SH-SY5Y cells and the relationship with the pathogenesis of AD

Neuroprotective effects of β7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease

[Effects of RNA Interference Targeting P2X7 Receptor on Microglial Phagocytosis of Amyloid-Β Protein].

Preventing Expression of the Nicotinic Receptor Subunit α7 in SH-SY5Y Cells with Interference RNA Indicates that this Receptor may Protect Against the Neurotoxicity of Aβ

The P38 Mitogen Activated Protein Kinase Regulates Β-Amyloid Protein Internalization Through the Α7 Nicotinic Acetylcholine Receptor in Mouse Brain.

Influence of APP_(SWE) Transfection on Nicotinic Receptors in Cultured Neuronal Cells

MLK3‐MKK3/6‐P38MAPK Cascades Following N‐methyl‐D‐aspartate Receptor Activation Contributes to Amyloid‐β Peptide‐induced Apoptosis in SH‐SY5Y Cells

Protective effect of EGb761 against Aβ1-42 -induced SHSY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway

Expression levels of the 7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells